Wholesale-Medical, Dental & Hospital Equipment & Supplies
Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
In the chart Earnings are multiplied by this value.
High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.
Years | 04-2015 | 04-2016 | 04-2017 | 04-2018 | 04-2019 | 04-2020 | 04-2021 | 04-2022 | 04-2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Net Margin | 5.1% | 3.5% | 3.1% | 3.7% | 1.5% | -11% | 2.6% | 3.1% | 3.2% | 2.9% |
ROA | 13% | 9.9% | 8.2% | 6.3% | 4.2% | -21% | 7.7% | 9.7% | 9.6% | 9.2% |
ROE | 15% | 13% | 12% | 14% | 5.6% | -70% | 16% | 19% | 18% | 20% |
The average Net Margin over the past 5 years is +0.56%.
The trend of Net Margin over the past 5 years is +0.45%.
The average ROA over the past 5 years is +2.74%.
The trend of ROA over the past 5 years is +1.76%.
The average ROE over the past 5 years is +0.46%.
The trend of ROE over the past 5 years is +4.33%.
Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.
Years | 04-2015 | 04-2016 | 04-2017 | 04-2018 | 04-2019 | 04-2020 | 04-2021 | 04-2022 | 04-2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Debt FCF | - | 9.17 | 8.69 | 7.95 | -61.71 | -2.07 | -0.91 | -0.48 | -0.64 | -0.56 |
Debt Equity | 0.48 | 0.73 | 0.74 | 0.74 | 0.52 | 0.71 | 0.72 | 0.47 | 0.47 | 0.47 |
MIN | ||||||||||
Graham Stability | - | - | - | 100% | 44% | -390% | - | - | - | -390% |
The Debt/FCF trailing twelve month is -0.56.
The trend of Debt/FCF over the past 5 years is 4.05.
Graham’s Stability measure stands at -3.89.
Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.
Years | 04-2016 | 04-2018 | 04-2020 | 04-2022 | Trend |
---|---|---|---|---|---|
Revenue | 2.7% | 3.4% | 5.6% | -0.43% | -1.3% |
Net Income | 1.4% | 0.55% | - | 2.4% | 4% |
Stockholders Equity | -3.6% | -5.2% | 10% | 7.3% | 1.5% |
FCF | - | - | - | - | 28% |
The Revenue CAGR over the past 5 years is +3.44%.
The trend of Revenue growth rate over the past 5 years is -1.29%.
The Earnings CAGR over the past 5 years is +0.55%.
The trend of Earnings growth rate over the past 5 years is +3.96%.
The Equity CAGR over the past 5 years is -5.21%.
The trend of Equity growth rate over the past 5 years is +1.52%.
The FCF CAGR over the past 5 years is -.
The trend of FCF growth rate over the past 5 years is +28.27%.